Rovi Corporation (NASDAQ:ROVI) reported that Rovi has renewed its discovery patent portfolio license contract with Funai Electric Co. Ltd., covering...
Pfizer Inc. (NYSE:PFE) starts enrollment in a Phase 2b clinical examination evaluating its untried Staphylococcus aureus multi-antigen vaccine, PF-06290510, in...